Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis 2015 NIAID 4R37AI047365-16 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis 2015 NIDDK 5K24DK092336-04 Patient-oriented and effectiveness research in chronic liver disease KIM, W. RAY STANFORD UNIVERSITY CA $124,529
Hepatitis 2015 NIDDK 2R01DK041876-27 Mechanisms of Liver Cell Injury GORES, GREGORY MAYO CLINIC ROCHESTER MN $357,750
Hepatitis 2015 NIAID 5R01AI095097-04 HIV co-infection and HCV-induced liver fibrosis in vivo SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $370,000
Hepatitis 2015 NIDDK 1P30DK097948-01A1 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,916
Hepatitis 2015 NIAAA 1R21AA022720-01A1 BMAL1: A Novel Regulator For Inflammatory Liver Injury YIN, LEI UNIVERSITY OF MICHIGAN MI $184,261
Hepatitis 2015 NIDA 5R01DA035146-03 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $580,906
Hepatitis 2015 NICHD 5R01HD062489-05 Pediatric Adverse Drug Reactions in NASH CHERRINGTON, NATHAN UNIVERSITY OF ARIZONA AZ $313,889
Hepatitis 2015 NIAID 5R01AI104494-02 A screen for antiviral compounds targeting the Hepatitis B Virus ribonuclease H TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $337,500
Hepatitis 2015 NIMHD 5R24MD008095-03 Reducing Asian Hepatitis B Disparities through Health Information Technology WEIR, ROSY ASSOCIATION/ASIAN PACIFIC CMTY HLTH ORGS CA $291,991
Hepatitis 2015 NIAID 5K22AI100935-02 Innate immune regulation during hepatitis C virus infection HORNER, STACY DUKE UNIVERSITY NC $108,000
Hepatitis 2015 NIAID 5R01AI050611-11 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $394,247
Hepatitis 2015 NIAID 5UM1AI068632-09 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $20,140,230
Hepatitis 2015 NICHD 5UM1AI068632-09 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,390,488
Hepatitis 2015 NCI 5UM1AI068636-09 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2015 NIAID 5UM1AI068636-09 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $42,646,161
Hepatitis 2015 NIDA 5UM1AI068636-09 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,727,032
Hepatitis 2015 NINDS 5UM1AI068636-09 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2015 OD 5UM1AI068636-09 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $545,000
Hepatitis 2015 NHLBI 5R21HL121740-02 The Risk of Transfusion Transmission of Hepatitis E Virus NELSON, KENRAD JOHNS HOPKINS UNIVERSITY MD $159,846
Hepatitis 2015 NIAID 5UM1AI069418-09 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $1,977,185
Hepatitis 2015 NIAID 5UM1AI069503-09 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $1,055,836
Hepatitis 2015 NIAID 5UM1AI069536-09 HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) SPECTOR, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,046,978
Hepatitis 2015 NIAID 5R01AI104887-03 Control of Viral Pathogenesis by Regulation of 2-5A Levels WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $713,295
Hepatitis 2015 NIDDK 5R01DK090794-05 Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral Infection FRENCH, SAMUEL UNIVERSITY OF CALIFORNIA LOS ANGELES CA $334,950
Hepatitis 2015 NIAID 5R21AI109791-02 HCV biology and inhibition visualized at the single molecule level WALTER, NILS UNIVERSITY OF MICHIGAN MI $194,375
Hepatitis 2015 NIAID 5R01AI108765-02 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $435,000
Hepatitis 2015 NIAID 5R21AI107631-02 Study of rodent HCV-GBV like viruses KAPOOR, AMIT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $237,288
Hepatitis 2015 NIDDK 5R01DK087977-05 The Role of Mitochondrial Dysfunction in Non-Alcoholic Fatty Liver Disease BROWNING, JEFFREY UT SOUTHWESTERN MEDICAL CENTER TX $366,541
Hepatitis 2015 NIAAA 5U01AA021838-03 Transcriptomics of Liver in Alcoholic Hepatitis NORDEN-KRICHMAR, TRINA UNIVERSITY OF CALIFORNIA-IRVINE CA $256,060
Hepatitis 2015 NIAAA 5U01AA021898-03 ALCOHOLIC HEPATITIS PATHOGENESIS AS DETERMINED FROM HUMAN LIVER TISSUE ANALYSIS FRENCH, SAMUEL LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $203,818
Hepatitis 2015 NIDDK 5R01DK090313-05 Hepatic Steatosis and ER Stress-Inducible Transcription Factor CREBH ZHANG, KEZHONG WAYNE STATE UNIVERSITY MI $330,600
Hepatitis 2015 NIAID 5K08AI102761-03 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $185,121
Hepatitis 2015 NIAID 5R01AI069000-10 Roles for microRNA-122 in hepatitis C virus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $393,160
Hepatitis 2015 NHLBI 5K01HL121010-02 The role of CD8+ T cells in the development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Hepatitis 2015 NIAID 5R01AI105035-03 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $543,750
Hepatitis 2015 NIGMS 5F31GM103259-03 HCV protease: from atomic mechanism for drug resistance to novel drug design SOUMANA, DJADE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $29,634
Hepatitis 2015 NIGMS 5R01GM100071-04 Nanofluidic Devices for Studying Assembly of Single Virus Particles JACOBSON, STEPHEN INDIANA UNIVERSITY BLOOMINGTON IN $293,619
Hepatitis 2015 NIAID 5R01AI070101-09 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $440,000
Hepatitis 2015 NIDA 5K23DA031612-04 Supporting Health in Drug Treatment Court for Women with HIV or Hepatitis C MORSE, DIANE UNIVERSITY OF ROCHESTER NY $172,275
Hepatitis 2015 NIAID 1R01AI110358-01A1 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $387,500
Hepatitis 2015 NIDDK 5R01DK077704-07 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Hepatitis 2015 NIAID 5R01AI096882-04 Persistent hepatitis C virus replication and T cell immunity in pregnancy WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $584,545
Hepatitis 2015 NIAID 5R01AI099506-02 Modulation of internal ribosome entry by ribosomal protein RPS25 SARNOW, PETER STANFORD UNIVERSITY CA $578,185
Hepatitis 2015 NIAAA 5P50AA011999-17 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $198,195
Hepatitis 2015 NIAID 5F32AI106178-03 Mechanistic Studies of the Function of Desmosterol Homeostasis in HCV Replication VILLAREAL, VALERIE ANNE HARVARD MEDICAL SCHOOL MA $57,962
Hepatitis 2015 NIDDK 5R01DK099055-02 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $336,086
Hepatitis 2015 NIAID 1R01AI114748-01 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis 2015 NCI 1R01CA190678-01 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $381,691
Hepatitis 2015 NHLBI 1R01HL119830-01A1 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Hepatitis 2015 NCI 1R01CA190776-01 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $666,229
Hepatitis 2015 NICHD 5R01HD075549-02 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $313,134
Hepatitis 2015 NIAID 5R01AI097318-05 Underlying Mechanisms of ApoE in HCV Infection and Assembly LUO, GUANGXIANG UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $367,500
Hepatitis 2015 NIDDK 5K23DK085150-05 Non-Alcoholic Fatty Liver Disease and Obstructive Sleep Apnea: Mechanistic Links SUNDARAM, SHIKHA UNIVERSITY OF COLORADO DENVER CO $175,494
Hepatitis 2015 NCI 1K99CA191152-01 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $109,620
Hepatitis 2015 NIDA 5R01DA012568-17 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,226,902
Hepatitis 2015 NIAID 5R01AI106005-02 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $450,000
Hepatitis 2015 NIDDK 5K08DK101754-02 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $153,457
Hepatitis 2015 NIAID 1R21AI115476-01 T cell responses at the site of infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $261,000
Hepatitis 2015 NIAID 1R03AI115171-01 Exploring HCV infection in engineered cultures of iPSC-derived human liver cells KHETANI, SALMAN COLORADO STATE UNIVERSITY CO $48,645
Hepatitis 2015 NCI 5R21CA185707-02 Tethered Cationic Lipoplex Nanoparticle Assay for Liver Cancer Detection and Surv LEE, LY OHIO STATE UNIVERSITY OH $159,393
Hepatitis 2015 NIAID 5R01AI097552-02 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis 2015 NIDA 5K01DA036452-02 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis 2015 NIDA 5R01DA035736-03 CYP2D6 Genotype and Cognitive Deficits in Methamphetamine Users with/without HIV CHERNER, MARIANA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $333,369
Hepatitis 2015 NIAID 5R01AI091707-05 Type I interferon-stimulated genes and the antiviral immune response RICE, CHARLES ROCKEFELLER UNIVERSITY NY $422,500
Hepatitis 2015 NIEHS 5R01ES021375-04 PCBs worsen obesity/metabolic syndrome through 'toxic metabolic endotoxemia' CAVE, MATTHEW UNIVERSITY OF LOUISVILLE KY $337,500
Hepatitis 2015 NIAAA 5R01AA012863-15 Mechanisms of Liver Injury by Hepatitis C and Alcohol WEINMAN, STEVEN UNIVERSITY OF KANSAS MEDICAL CENTER KS $501,081
Hepatitis 2015 NIAID 5R01AI100748-04 Lamivudine and its Impact on Perinatal HBV Transmission in HIV/HBV Coinfection BHATTACHARYA, DEBIKA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $386,315
Hepatitis 2015 NIDDK 5R01DK088114-05 Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD) ORAL, ELIF UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis 2015 NIGMS 5R01GM104503-05 A Targeted Preemptive Approach to Addressing Mitochondrial Toxicity of Nucleoside BUOLAMWINI, JOHN ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $244,241
Hepatitis 2015 NIAID 5U19AI109965-02 5820 Novel Nucleic Acid Sensing NLRs and Innate Immunity to Viruses TING, JENNY UNIV OF NORTH CAROLINA CHAPEL HILL NC $414,750
Hepatitis 2015 NIAID 5U19AI109965-02 5821 Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $408,220
Hepatitis 2015 NIAID 5U19AI109965-02 5825 Protein Purification and Biochemistry DUNCAN, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $328,604
Hepatitis 2015 NIAID 5R01AI111970-02 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,127,672
Hepatitis 2015 NIDA 5R01DA025885-07 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $554,460
Hepatitis 2015 NIDDK 2R01DK074932-09 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,969
Hepatitis 2015 NIDDK 5K01DK095031-05 Interactions between type I and III interferon during resolution of HCV infection SCHOGGINS, JOHN UT SOUTHWESTERN MEDICAL CENTER TX $102,087
Hepatitis 2015 NICHD 2R01HD041230-11 Prenatal Metabolic Porgramming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Hepatitis 2015 NIDDK 1R01DK101941-01A1 Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients GARG, ABHIMANYU UT SOUTHWESTERN MEDICAL CENTER TX $363,375
Hepatitis 2015 NIAID 1R01AI110577-01A1 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $479,012
Hepatitis 2015 NIDDK 5K23DK090209-04 Gender and hormonal influences on liver fibrosis after transplant for hepatitis C FORDE, KIMBERLY UNIVERSITY OF PENNSYLVANIA PA $182,110
Hepatitis 2015 NIGMS 5P41GM103314-42 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,468,072
Hepatitis 2015 NIMH 5K01MH097847-03 An Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C RETHORST, CHAD UT SOUTHWESTERN MEDICAL CENTER TX $148,640
Hepatitis 2015 NIMHD 5R24MD002756-08 Dissemination of an Evidence-based HepB Intervention to Korean Churches MA, GRACE TEMPLE UNIV OF THE COMMONWEALTH PA $458,425
Hepatitis 2015 NIDDK 5K23DK095707-03 An Assessment of Liver Disease in HIV-infected and HIV/HBV Co-infected Tanzanians HAWKINS, CLAUDIA NORTHWESTERN UNIVERSITY AT CHICAGO IL $126,865
Hepatitis 2015 NIAID 5R01AI099245-04 The PIP2-virus interface and PI 4-kinase: novel biology and validation targets GLENN, JEFFREY STANFORD UNIVERSITY CA $1,027,579
Hepatitis 2015 NIDA 5R01DA033871-03 Action Plans & Memory Consolidation: Reducing HIV Risk in Drug Users STACY, ALAN CLAREMONT GRADUATE UNIVERSITY CA $397,018
Hepatitis 2015 NIDA 5K24DA035684-02 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $168,171
Hepatitis 2015 NIDDK 1K08DK099412-01A1 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $152,874
Hepatitis 2015 NIDA 5K24DA034621-04 Patient Oriented Research in Hepatitis C-infected Injection Drug Users SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $118,638
Hepatitis 2015 NIDDK 7R01DK085252-05 LPS binding to TLR4 regulates hepatic stellate cell activation and fibrosis SEKI, EKIHIRO CEDARS-SINAI MEDICAL CENTER CA $369,750
Hepatitis 2015 NIAID 5K08AI097322-04 Antivirals for Hepatitis C Targeting Phosphoinositide Metabolism GELMAN, MICHAEL STANFORD UNIVERSITY CA $133,191
Hepatitis 2015 NIAID 5R03AI109460-02 Hepatitis B Virus diversity and ribonuclease H inhibitor efficacy TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis 2015 NIAID 1R21AI107252-01A1 Anti-HBV therapeutics based on rare-cutting targeted endonucleases JEROME, KEITH FRED HUTCHINSON CANCER RESEARCH CENTER WA $203,715
Hepatitis 2015 NIAID 5R01AI095690-05 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $368,389
Hepatitis 2015 NIDDK 5K08DK101757-02 Optimization and control of hepatocyte activity via biofunctional modification WERTHEIM, JASON NORTHWESTERN UNIVERSITY AT CHICAGO IL $151,311
Hepatitis 2015 NIAID 5R01AI094409-05 Antisense Mediated Treatment of Hepatitis B Virus Infection GARAIGORTA, URTZI SCRIPPS RESEARCH INSTITUTE CA $768,816
Hepatitis 2015 NIAID 1U01AI115711-01 Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant GRINSPOON, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $587,655
Hepatitis 2015 NIAID 1U01AI115714-01 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $601,291
Hepatitis 2015 NCI 5R01CA164029-04 Murine Model of HCV-Associated Human Liver Cancer LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $470,695
Hepatitis 2015 NIDDK 5R01DK097374-03 Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus TAI, ANDREW UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis 2015 NCI 5R01CA166213-04 Super-infection and virus spread during chronic hepadnaviral infection GUDIMA, SEVERIN UNIVERSITY OF KANSAS MEDICAL CENTER KS $319,945
Hepatitis 2015 NIAID 5R01AI009484-46 Pathogenesis of Persistent Viral Infection OLDSTONE, MICHAEL SCRIPPS RESEARCH INSTITUTE CA $473,750
Hepatitis 2015 NIAID 5R01AI072613-09 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $546,673
Hepatitis 2015 NIAID 5R01AI094469-05 Preclinical Development of SB 44 as an Orally Bioavailable Anti-HBV Agent IYER, RADHAKRISHNAN SPRING BANK TECHNOLOGIES, INC. MA $901,490
Hepatitis 2015 NCI 5R01CA163805-05 Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans JUON, HEE-SOON THOMAS JEFFERSON UNIVERSITY PA $189,113
Hepatitis 2015 NIAID 5U19AI111825-02 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $632,104
Hepatitis 2015 NCI 5R01CA158271-04 Hepatocyte Nox proteins in the pathogenesis of hepatocellular carcinoma CHOI, JINAH UNIVERSITY OF CALIFORNIA, MERCED CA $276,582
Hepatitis 2015 NCI 5R01CA168912-02 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI GEORGIA REGENTS UNIVERSITY GA $319,966
Hepatitis 2015 NIDDK 5R01DK093526-04 Tim-3-mediated IL-12 dysregulation in antiviral responses to HCV infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $317,550
Hepatitis 2015 NCI 5R01CA161694-04 Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse SELL, STEWART WADSWORTH CENTER NY $292,725
Hepatitis 2015 NIAID 5R01AI099284-04 Hepatitis C antivirals: Mechanism of action, combination efficacy and resistance RICE, CHARLES ROCKEFELLER UNIVERSITY NY $735,361
Hepatitis 2015 NHLBI 5R01HL105704-05 Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing CHIU, CHARLES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $573,600
Hepatitis 2015 NIDDK 1R01DK102597-01A1 NAFLD: Mechanisms and Treatments TIMCHENKO, NIKOLAI CINCINNATI CHILDRENS HOSP MED CTR OH $346,630
Hepatitis 2015 NIAID 5R21AI111250-02 Function of Lipid Droplets in Viral Entry and Membrane Fusion TANG, HENGLI FLORIDA STATE UNIVERSITY FL $181,384
Hepatitis 2015 NIDDK 7R01DK088940-05 Aerobic fitness, mitochondrial dysfunction, and fatty liver disease THYFAULT, JOHN UNIVERSITY OF KANSAS MEDICAL CENTER KS $283,125
Hepatitis 2015 NIDDK 5R01DK095862-03 Protective role of adenosine 2A receptor in NAFLD WU, CHAODONG TEXAS A&M AGRILIFE RESEARCH TX $317,242
Hepatitis 2015 NIDDK 5R01DK096076-03 Role of Dab2 in Fatty Liver Disease LEITINGER, NORBERT UNIVERSITY OF VIRGINIA VA $343,650
Hepatitis 2015 NIGMS 5R01GM064803-11 Genome-Scale Analysis of RNA Virus Tertiary Structure WEEKS, KEVIN UNIV OF NORTH CAROLINA CHAPEL HILL NC $317,677
Hepatitis 2015 NIDA 5R01DA033777-04 Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs MARKOWITZ, MARTIN AARON DIAMOND AIDS RESEARCH CENTER NY $916,984
Hepatitis 2015 NIDDK 5R01DK098655-03 Hepatic insulin resistance and metabolic disease WHITE, MORRIS CHILDREN'S HOSPITAL CORPORATION MA $459,892
Hepatitis 2015 NCI 5R03CA186203-02 Investigating the cause of racial/ethnic disparity in hepatocellular cancer risk SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $82,438
Hepatitis 2015 NCI 1F32CA192633-01 Disruption of the Host DNA Damage Response by Hepatitis C Virus MITCHELL, JONATHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $52,406
Hepatitis 2015 NIAID 5U19AI057229-12 7617 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination DAVIS, MARK STANFORD UNIVERSITY CA $265,955
Hepatitis 2015 NIEHS 1F30ES025099-01 Xenobiotic Receptors Modulate PCB-induced Steatohepatitis CLAIR, HEATHER UNIVERSITY OF LOUISVILLE KY $33,854
Hepatitis 2015 NIAID 5R01AI094474-06 Development of a novel drug candidate that inhibits hepatitis B virus covalently GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $686,525
Hepatitis 2015 NIAID 5R01AI052447-13 Gene Silencing as an Antiviral Defense in Animal Cells DING, SHOU-WEI UNIVERSITY OF CALIFORNIA RIVERSIDE CA $505,177
Hepatitis 2015 NCI 5R01CA086978-12 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Hepatitis 2015 NIDA 5K24DA037034-02 Mentoring and Empowerment in the Context of HIV Care for At-Risk Populations JOHNSON, MALLORY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $183,707
Hepatitis 2015 NCI 1R01CA186566-01A1 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $832,002
Hepatitis 2015 NCI 9R01CA193244-05A1 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $375,706
Hepatitis 2015 NIDA 5R01DA016078-14 The Progression of Hepatitis C Among IDUs with HIV BALAGOPAL, ASHWIN JOHNS HOPKINS UNIVERSITY MD $703,923
Hepatitis 2015 NIDA 5R01DA031056-06 International Collaborative of prospective studies of HIV and Hepatitis in IDU PAGE, KIMBERLY UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $386,153
Hepatitis 2015 NIDDK 5R01DK101579-03 Physiology of Lipid Droplets and Triglyceride Storage FARESE, ROBERT HARVARD SCHOOL OF PUBLIC HEALTH MA $589,475
Hepatitis 2015 NIGMS 5R37GM056207-20 Simulation of Proton and Hydride Transfer in Enzymes HAMMES-SCHIFFER, SHARON UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $289,129
Hepatitis 2015 NCI 5R21CA183615-02 Functional Profiles of Hepatitis C Virus Genome at Single Nucleotide Resolution SUN, REN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $200,970
Hepatitis 2015 NCI 5R21CA183954-02 A novel mediator of obesity associated hepatocellular carcinoma (HCC) SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY VA $165,844
Hepatitis 2015 NIDA 5R01DA034637-03 Addressing Hepatitis C and Hepatocellular Carcinoma: Current and Future Epidemics HAGAN, HOLLY NEW YORK UNIVERSITY NY $667,893
Hepatitis 2015 NIDDK 5R01DK095962-03 Novel therapeutic approaches to treating chronic hepatitis B virus infection SU, LISHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $551,970
Hepatitis 2015 NIAAA 5R37AA009300-20 Lipid Aldehyde and Ethanol Induced Liver Damage PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $465,533
Hepatitis 2015 NIGMS 5R01GM105414-03 Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV BLACKARD, JASON UNIVERSITY OF CINCINNATI OH $295,471
Hepatitis 2015 NCI 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $42,319
Hepatitis 2015 NHLBI 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $35,168
Hepatitis 2015 NIA 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $3,445
Hepatitis 2015 NIAID 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $219,204
Hepatitis 2015 NICHD 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $16,009
Hepatitis 2015 NIDA 5P30AI094189-04 5955 Clinical CHAISSON, RICHARD JOHNS HOPKINS UNIVERSITY MD $26,425
Hepatitis 2015 NIDA 5R01DA022177-09 Opioids, HIV/HCV and host cell innate immunity HO, WENZHE TEMPLE UNIV OF THE COMMONWEALTH PA $234,774
Hepatitis 2015 NHLBI 5R01HL119485-02 Novel viruses and viral dynamics in multiple transfusion recipients KAPOOR, AMIT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $398,816
Hepatitis 2015 NIDA 1R21DA039010-01 Emotion Dysregulation and Risky Behavior Among People Who Inject Drugs MACKESY-AMITI, MARY UNIVERSITY OF ILLINOIS AT CHICAGO IL $238,683
Hepatitis 2015 NCI 5P01CA022443-38 6854 Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $324,758
Hepatitis 2015 NCI 5P01CA022443-38 6867 Instrumentation LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $68,573
Hepatitis 2015 NCI 5P01CA022443-38 6868 Virus Production MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $101,776
Hepatitis 2015 NCI 5R01CA089121-09 Hepatitis C Virus and Hepatocellular Carcinoma DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $237,038
Hepatitis 2015 NIDA 2R01DA027379-04 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $522,235
Hepatitis 2015 NIDA 5R01DA031059-04 Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $612,390
Hepatitis 2015 NIAAA 1K23AA023753-01 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $186,192
Hepatitis 2015 NIDA 1R34DA038530-01A1 A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results FRIMPONG, JEMIMA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $378,599
Hepatitis 2015 NIAID 2R01AI085087-05A1 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $259,625
Hepatitis 2015 NCI 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $40,495
Hepatitis 2015 NHLBI 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $28,872
Hepatitis 2015 NIA 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $5,624
Hepatitis 2015 NIAID 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $230,454
Hepatitis 2015 NICHD 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $11,249
Hepatitis 2015 NIDA 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $22,872
Hepatitis 2015 NIDDK 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $12,779
Hepatitis 2015 NIGMS 5P30AI045008-17 6413 Clinical Core FRANK, IAN UNIVERSITY OF PENNSYLVANIA PA $12,779
Hepatitis 2015 NIDDK 5R01DK100257-03 HBV replication and persistence in mouse models OU, J.-H. JAMES UNIVERSITY OF SOUTHERN CALIFORNIA CA $358,785
Hepatitis 2015 NIAID 5R01AI079031-07 Understanding human neutralizing antibodies to hepatitis C virus LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $548,397
Hepatitis 2015 NCI 5R01CA114102-09 The RB pathway in liver cancer SAGE, JULIEN STANFORD UNIVERSITY CA $278,271
Hepatitis 2015 NIDA 5R01DA016065-12 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $697,750
Hepatitis 2015 NIDA 5R01DA031074-05 Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs GARFEIN, RICHARD UNIVERSITY OF CALIFORNIA SAN DIEGO CA $568,934
Hepatitis 2015 NIDDK 5K23DK099422-03 The Impact of Obstructive Sleep Apnea on Non-Alcoholic Fatty Liver Disease COREY, KATHLEEN MASSACHUSETTS GENERAL HOSPITAL MA $184,691
Hepatitis 2015 NIAID 5R01AI069285-09 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $337,500
Hepatitis 2015 NIAID 5R21AI109100-02 Damage-associated Alarmin Key to Immune Responses in Viral Hepatitis SUN, JIAREN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $193,750
Hepatitis 2015 NIDDK 5R42DK101240-03 Development of PAR2 Inhibitors for the Treatment of Nonalcoholic steatohepatitis KULIOPULOS, ATHAN OASIS PHARMACEUTICALS MA $871,014
Hepatitis 2015 NIAID 5R21AI103838-03 Molecular Mechanisms of ZAP/ISG20 mediated HBV RNA Decay GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $195,000
Hepatitis 2015 NIAID 5R01AI113267-03 Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors GUO, JU-TAO BARUCH S. BLUMBERG INSTITUTE PA $669,728
Hepatitis 2015 NIAAA 5U01AA021912-03 Targeting DAMPs in Alcoholic Hepatitis SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $377,574
Hepatitis 2015 NIDA 5U01DA036267-03 MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) GORBACH, PAMINA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,401,419
Hepatitis 2015 NIDDK 5F30DK099017-03 Structure-function determination of the Hepatitis C Virus negative RNA strand's 3'-terminal sequence PHAM, EDWARD STANFORD UNIVERSITY CA $33,230
Hepatitis 2015 NIAID 5R01AI067417-11 Molecular Modulation of Virus Capsid Assembly ZLOTNICK, ADAM INDIANA UNIVERSITY BLOOMINGTON IN $428,479
Hepatitis 2015 OD 5R01OD011095-23 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $435,522
Hepatitis 2015 NIAAA 5R01AA021133-03 RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse PROESCHOLD-BELL, RAE JEAN DUKE UNIVERSITY NC $670,501
Hepatitis 2015 NIAAA 5U01AA021908-03 Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis BATALLER, RAMON UNIV OF NORTH CAROLINA CHAPEL HILL NC $1,169,040
Hepatitis 2015 NIGMS 1SC1GM111158-01A1 Biological Studies of alpha-Hydroxytropolones MURELLI, RYAN BROOKLYN COLLEGE NY $381,100
Hepatitis 2015 NCI 5R21CA184920-02 (PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression MARTINEZ, JESSE UNIVERSITY OF ARIZONA AZ $131,805
Hepatitis 2015 NIDA 5R13DA022952-10 International Society for Addiction Medicine Annual Conference BUNT, GREGORY AMERICAN SOCIETY OF ADDICTION MEDICINE MD $40,000
Hepatitis 2015 NIDDK 5P01DK059820-14 5731 SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease MOORE, DAVID BAYLOR COLLEGE OF MEDICINE TX $353,529
Hepatitis 2015 NIGMS 5R01GM081346-07 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $292,959
Hepatitis 2015 NIAID 5U19AI082630-07 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $498,302
Hepatitis 2015 NIAID 5U19AI082630-07 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $482,876
Hepatitis 2015 NIAID 5U19AI082630-07 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $414,352
Hepatitis 2015 NIAID 5U19AI082630-07 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $250,000
Hepatitis 2015 NIAID 5U19AI082630-07 7594 Administrative Core CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $171,977
Hepatitis 2015 NIAID 5U19AI082630-07 7595 Pilot/Feasibility Studies Program CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $68,500
Hepatitis 2015 NIAID 5U19AI082630-07 7596 Tissue and Clinical Core KIM, ARTHUR MASSACHUSETTS GENERAL HOSPITAL MA $284,557
Hepatitis 2015 NIAID 5U19AI082630-07 7597 Virology Core ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $106,547
Hepatitis 2015 FIC 5D43TW009771-02 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $285,538
Hepatitis 2015 NIDDK 5R01DK091601-05 Genetic determinants of NAFLD severity and progression DISTEFANO, JOHANNA TRANSLATIONAL GENOMICS RESEARCH INST AZ $498,594
Hepatitis 2015 NIAID 1R01AI116639-01 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Hepatitis 2015 NIDDK 1R01DK104735-01 TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS FINCK, BRIAN WASHINGTON UNIVERSITY MO $410,065
Hepatitis 2015 NIAID 5R01AI098126-04 Role of HCV in aberrant APC activation/function HAHN, YOUNG UNIVERSITY OF VIRGINIA VA $392,100
Hepatitis 2015 NIDA 5R01DA034086-04 Intensive Models of HCV Care for Injection Drug Users LITWIN, ALAIN ALBERT EINSTEIN COLLEGE OF MEDICINE NY $703,813
Hepatitis 2015 NIDDK 5R01DK044533-18 Mechanism(s) of Hepatocyte Transformation by the Hepatitis B Virus X Protein ANDRISANI, OURANIA PURDUE UNIVERSITY IN $317,018
Hepatitis 2015 NIDDK 1R01DK104956-01 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $561,953
Hepatitis 2015 NIAAA 5U01AA021856-03 Microbiome as Therapeutic Target in Alcoholic Hepatitis SCHNABL, BERND UNIVERSITY OF CALIFORNIA SAN DIEGO CA $414,673
Hepatitis 2015 NIAID 5K08AI108629-02 Interferon Effector Gene Activation to Circumvent Viral Impedance FUSCO, DAHLENE MASSACHUSETTS GENERAL HOSPITAL MA $186,192
Hepatitis 2015 NCI 5F31CA167872-04 Characterization of novel regulators of amino acid-sensitive mTORC1 signaling SCHWEITZER, LAWRENCE MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $43,120
Hepatitis 2015 NIDA 5U01DA033336-03 Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry LEE, JOSHUA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $672,308
Hepatitis 2015 NCI 1U54CA193417-01 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $328,252
Hepatitis 2015 NIAAA 5F30AA022283-03 The Role of miR-122 in Alcoholic Liver Disease SATISHCHANDRAN, ABHISHEK UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $29,567
Hepatitis 2015 NIAID 5U19AI109662-02 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $424,660
Hepatitis 2015 NIAID 5U19AI109662-02 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $739,116
Hepatitis 2015 NIAID 5U19AI109662-02 7135 Novel Interferons and small molecule enhancers of the interferon pathway GARCIA, KENAN STANFORD UNIVERSITY CA $498,840
Hepatitis 2015 NIAAA 5U01AA021883-04 Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-ADMIN) CRABB, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $37,830
Hepatitis 2015 NIAID 5R01AI074667-07 Mechanism of Hepatitis E Virus Replication and Pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $402,500
Hepatitis 2015 NIAAA 5U01AA021902-04 Novel Therapies in Alcoholic Hepatitis - UMMS Admin Core SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $40,618
Hepatitis 2015 NIDA 5R01DA033866-04 Brief intervention for drug-using rural women at high-risk for HIV/HCV TINDALL, MICHELE UNIVERSITY OF KENTUCKY KY $537,382
Hepatitis 2015 NHGRI 5P20HG007261-03 GUIDE: Genomic Uses in Infectious Diseases and Epidemics GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $268,773
Hepatitis 2015 NCI 5R01CA180083-03 (PQA4) Point-of-Care Test of Exposure to Hepatocellular Carcinoma Risk by V-Chip QIN, LIDONG METHODIST HOSPITAL RESEARCH INSTITUTE TX $521,783
Hepatitis 2015 NIMH 5R01MH085538-06 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $508,271
Hepatitis 2015 NIDA 1R21DA039345-01 Facilitating HCV Treatment through Tailored Prenatal Care for HCV Infected, Substance using Pregnant Women KRANS, ELIZABETH MAGEE-WOMEN'S RES INST AND FOUNDATION PA $183,185
Hepatitis 2015 NIAID 1R21AI117213-01 Impact of species-specific host responses on restriction of hepatotropic viruses PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $222,688
Hepatitis 2015 NCI 5U01AI069919-10 IeDEA West -Africa collaboration DABIS, FRANCOIS ADERA FR $225,000
Hepatitis 2015 NIAID 5U01AI069919-10 IeDEA West -Africa collaboration DABIS, FRANCOIS ADERA FR $1,136,149
Hepatitis 2015 NICHD 5U01AI069919-10 IeDEA West -Africa collaboration DABIS, FRANCOIS ADERA FR $300,000
Hepatitis 2015 NIDDK 5R01DK099226-02 G Protein pathways as Novel Therapeutic and Diagnostic Targets in Liver Fibrosis GHOSH, PRADIPTA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $232,500
Hepatitis 2015 NCI 1R21CA188472-01A1 Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma RAY, RATNA SAINT LOUIS UNIVERSITY MO $212,479
Hepatitis 2015 NIDDK 1R03DK105303-01 Hepatocyte Notch Signaling Regulates NASH PAJVANI, UTPAL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $80,000
Hepatitis 2015 NIAAA 5U01AA021840-04 Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU) CRABB, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $918,831
Hepatitis 2015 NIDA 5R01DA033673-04 Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities GOLDSAMT, LLOYD NEW YORK UNIVERSITY NY $574,518
Hepatitis 2015 NIAID 5R01AI107301-03 Genetic viral and host adaptations to breach species barriers of HCV PLOSS, ALEXANDER PRINCETON UNIVERSITY NJ $402,500
Hepatitis 2015 NIAID 5R41AI112114-02 Development of broad spectrum Hepatitis C Virus NS3/4A protease inhibitors JOHNSON, MICHAEL NOVALEX THERAPEUTICS, INC. IL $300,000
Hepatitis 2015 NIDA 5U01DA036935-02 HIV Disease Outcomes in Drug Users in Clinical Practice MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $1,474,110
Hepatitis 2015 NIAID 5K24AI108516-03 HIV, HCV, and gender effects on Liver, Bone, and Vascular Health TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $133,824
Hepatitis 2015 NIGMS 5R44GM088948-03 Direct RT-PCR detection of RNA pathogens in crude samples ZHANG, ZHIAN DNA POLYMERASE TECHNOLOGY, INC. MO $416,573
Hepatitis 2015 NIAID 5R01AI108403-03 Antibody-Mediated Suppression of Antiviral Inflammasome Activation COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $442,767
Hepatitis 2015 NIAAA 5R01AA019976-06 Developmental pathways, environmental agents, and epigenetics in liver disease ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $576,972
Hepatitis 2015 NIAAA 5U01AA021887-05 Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis NIETO, NATALIA UNIVERSITY OF ILLINOIS AT CHICAGO IL $372,013
Hepatitis 2015 NIDDK 5R03DK101863-02 TLR4 in Obesity-Driven Liver Fibrosis CAVIGLIA, JORGE COLUMBIA UNIVERSITY HEALTH SCIENCES NY $200,000
Hepatitis 2015 NCI 5R01CA138698-06 Epidemiologic Study of Hepatocellular Carcinoma in the US YU, HERBERT UNIVERSITY OF HAWAII AT MANOA HI $1,460,631
Hepatitis 2015 NIDDK 5R01DK061498-14 Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease CZAJA, MARK ALBERT EINSTEIN COLLEGE OF MEDICINE NY $363,225
Hepatitis 2015 NIAAA 5U01AA021907-04 Novel Therapies in alcoholic hepatitis - UMMS Translational Program SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $343,310
Hepatitis 2015 NIAAA 5U01AA021890-04 Novel therapeutics for alcoholic hepatitis - Cleveland Translational Component NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $265,075
Hepatitis 2015 NIAID 5R01AI089957-05 Novel antiviral activities of tumor necrosis factor-alpha DUSTIN, LYNN UNIVERSITY OF OXFORD UK $270,000
Hepatitis 2015 NIDA 5R01DA036514-02 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $702,446
Hepatitis 2015 NIDDK 5R01DK052951-18 Genetic and molecular effects on hepatocyte nucleocytoplasm protein aggregation OMARY, BISHR UNIVERSITY OF MICHIGAN MI $387,500
Hepatitis 2015 NIDDK 5R01DK053892-17 HNF4 Isoforms in Physiology and Disease SLADEK, FRANCES UNIVERSITY OF CALIFORNIA RIVERSIDE CA $380,000
Hepatitis 2015 NIDDK 5R01DK090014-05 CARD14 is essential for hepatitis C virus replication and activation of NFKB TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $430,650
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer